Online Certification & Courses

EurekAlert from AAAS
Home About us
Advanced Search
3-Feb-2012 21:05
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia Gallery

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

News By Subject
Search this subject
Medicine/Health
Key: Meeting Journal Funder Dissertation
Public Release: 3-Feb-2012
Brain & Language
Hearing metaphors activates brain regions involved in sensory experience
New brain imaging research reveals that a region of the brain important for sensing texture through touch, the parietal operculum, is also activated when someone listens to a sentence with a textural metaphor. The same region is not activated when a similar sentence expressing the meaning of the metaphor is heard.
National Institutes of Health, National Science Foundation

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University

Public Release: 3-Feb-2012
Why 2 new studies represent important breakthrough in Alzheimer's disease research
Two separate research findings have the potential to give us a much more sophisticated understanding of what goes wrong in Alzheimer's disease and what can be done to prevent or repair damage in the brain.

Contact: Alice L. Kirkman
akirkman@ahaf.org
301-556-9349
AHAF-American Health Assistance Foundation

Public Release: 3-Feb-2012
American Journal of Human Genetics
Whole exome sequencing identifies cause of metabolic disease
Sequencing a patient's entire genome to discover the source of his or her disease is not routine, but geneticists are getting close. A case report shows how researchers can combine a simple blood test with an "executive summary" scan of the genome to diagnose a severe glycosylation disorder.
National Institutes of Health, Rocket Fund

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University

Public Release: 3-Feb-2012
American Stroke Association's International Stroke Conference 2012
Study: Stroke victims recover much better after temporary stent procedure
A new way of opening blocked arteries in the brain using a removable stent system in people suffering strokes brought remarkably positive results in how those patients recovered from the strokes, according to a study presented Feb. 3 at the American Stroke Association's annual conference in New Orleans.
Covidien

Contact: Todd Murphy
murphyt@ohsu.edu
503-494-8231
Oregon Health & Science University

Public Release: 3-Feb-2012
Science
Discovery of extremely long-lived proteins may provide insight into cell aging
One of the big mysteries in biology is why cells age. Now scientists at the Salk Institute for Biological Studies report that they have discovered a weakness in a component of brain cells that may explain how the aging process occurs in the brain.

Contact: Andy Hoang
Ahoang@salk.edu
619-861-5811
Salk Institute

Public Release: 3-Feb-2012
Journal of Black Psychology
Dieting with the denomination, determination
According to a new study, those starting new weight loss programs may be surprised to find out that both location and level of experience may influence their success. A recent article published in the Journal of Black Psychology (a journal from the Association of Black Psychologists, published by SAGE) finds that African-American women beginning a new group weight loss program are more successful if they are less experienced with weight management and if the program meets in a church.

Contact: Ashley Loar
ashley.loar@sagepub.com
805-410-7111
SAGE Publications

Public Release: 3-Feb-2012
Molecular Cancer Therapeutics
Study published in Neuro-Oncology shows brain tumor eradication and prolonged survival
Tocagen Inc. today announced the publication of data showing the company's investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma. Almost all mice receiving the top dose of Toca 511 followed by 5-FC were still alive at 180 days, which was the termination date for the experiment, whereas all control mice died by day 43. The article was published today in the February issue of the Neuro-Oncology journal.
Tocagen Inc.

Contact: Carin Canale
carin@canalecomm.com
619-849-6001
Canale Communications

Public Release: 3-Feb-2012
Canadian Journal of Physiology and Pharmacology
Regular use of vitamin and mineral supplements could reduce the risk of colon cancer
Could the use of vitamin and mineral supplements in a regular diet help to reduce the risk of colon cancer and protect against carcinogens? A study published in the Canadian Journal of Physiology and Pharmacology found that rats given regular multivitamin and mineral supplements showed a significantly lower risk of developing colon cancer when they were exposed to carcinogens.

Contact: Ignacimuthu Savarimuthu
bhaskar_sci@yahoo.com
Canadian Science Publishing (NRC Research Press)

Public Release: 3-Feb-2012
Pediatric Allergy, Immunology and Pulmonology
Coughing and other respiratory symptoms improve within weeks of smoking cessation
A new study shows that 18- to 24-year olds who stop smoking for at least two weeks report substantially fewer respiratory symptoms, especially coughing. The study appears in the peer-reviewed journal Pediatric Allergy, Immunology, and Pulmonology.

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 3-Feb-2012
International Stroke Conference
New device removes stroke-causing blood clots better than standard treatment
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles Health Sciences

Public Release: 3-Feb-2012
UC San Diego Moores Cancer Center offers new hope for deadly brain tumor
In the United States, each year, approximately 10,000 patients are affected by recurrant glioblastoma multiforme. Now, a novel investigational device – available only at clinical trial sites – is offering new hope to these patients.

Contact: Kim Edwards
kedwards@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 3-Feb-2012
Schooling protects fleeing children from disease
Refugee children have scant access to medical care and are particularly vulnerable to disease. Fresh research results from the University of Copenhagen show that just a few hours of schooling a week may have a pronounced positive impact on their health not only in childhood but later in life when they achieve adulthood.

Contact: Associate Professor Tania Dræbel
mafl@sund.ku.dk
01-145-416-17998
University of Copenhagen

Public Release: 3-Feb-2012
American Stroke Association’s 2012 International Stroke Conference
Stroke: Journal of the American Heart Association
Warfarin and aspirin are similar in heart failure treatment
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
NIH/National Institute of Neurological Disorders and Stroke

Contact: ASA News Media Office
ahamediarelations@heart.org
214-706-1173
American Heart Association

Public Release: 3-Feb-2012
American Stroke Association’s 2012 International Stroke Conference
Stroke: Journal of the American Heart Association
Rare mutations may help explain aneurysm in high-risk families
An innovative approach to genome screening has provided clues about rare mutations that may make people susceptible to brain aneurysms, predisposing them to brain bleeds, according to preliminary late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
NIH/National Institute of Neurological Disorders and Stroke

Contact: ASA News Media Office
ahamediarelations@heart.org
214-706-1173
American Heart Association

Public Release: 3-Feb-2012
Deutsches Ärzteblatt International
Vitamin D deficiency in geriatric patients
The great majority of geriatric patients in a German rehabilitation hospital were found to have vitamin D deficiency. Stefan Schilling presents his study results in this week's issue of Deutsches Ärzteblatt International.

Contact: Dr. med. Stefan Schilling
s.schilling@vereinigtehospitien.de
Deutsches Aerzteblatt International

Public Release: 3-Feb-2012
American Stroke Association’s 2012 International Stroke Conference
Stroke: Journal of the American Heart Association
New drug doesn't improve disability among stroke patients
A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
SYGNIS Bioscience

Contact: ASA News Media Office
ahamediarelations@heart.org
214-706-1173
American Heart Association

Public Release: 3-Feb-2012
American Stroke Association’s 2012 International Stroke Conference
Stroke: Journal of the American Heart Association
Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
National Institutes of Health, NIH/National Institute of Neurological Diseases and Stroke

Contact: ASA News Media Office
ahamediarelations@heart.org
214-706-1173
American Heart Association

Public Release: 3-Feb-2012
American Stroke Association’s 2012 International Stroke Conference
Stroke: Journal of the American Heart Association
New device performs better than old for removing blood clots
An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference.
Covidien

Contact: ASA News Media Office
ahamediarelations@heart.org
214-706-1173
American Heart Association

Public Release: 3-Feb-2012
Cancer Prevention Research
Soy isoflavone supplements did not provide breast cancer protections
Findings suggest the effects of food may be more complex. Adverse effect observed in younger women.

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research

Public Release: 3-Feb-2012
Journal of Psychopharmacology
Making sense of addiction terminology
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators.

Contact: Mithu Lucraft
mithu.lucraft@sagepub.co.uk
44-020-732-42223
SAGE Publications

Public Release: 3-Feb-2012
PLoS ONE
NYU Courant researchers weigh methods to more accurately measure genome sequencing
Researchers at New York University's Courant Institute of Mathematical Sciences evaluate some current methods to sequence individual genomes -- a study that serves as a "stress test" of the efficacy of these practices.
National Science Foundation, Abraxis BioScience LLC

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University

Public Release: 3-Feb-2012
Physical Biology
New technology to tackle treatment-resistant cancers
Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies.

Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics

Public Release: 3-Feb-2012
International Stroke Conference
New technique dissolves blood clots in the brain and lowers risk of brain damage after stroke
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage who could function independently by 10 to 15 percent six months following the procedure.

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions

Public Release: 3-Feb-2012
Journal of Neuroscience Research
New procedure repairs severed nerves in minutes, restoring limb use in days or weeks
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.

Contact: Ben Norman
Lifesciencenews@wiley.com
44-012-437-70375
Wiley-Blackwell

Public Release: 3-Feb-2012
American Journal of Respiratory and Critical Care Medicine
Breastfeeding and lung function at school age: Does maternal asthma modify the effect?
Breastfeeding is associated with improved lung function at school age, particularly in children of asthmatic mothers, according to a new study from researchers in Switzerland and the UK.

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society